Long-term effects of an antimicrobial stewardship programme at a tertiary-care teaching hospital.

[1]  S. Michie,et al.  Interventions to improve antibiotic prescribing practices for hospital inpatients. , 2017, The Cochrane database of systematic reviews.

[2]  G. Roselle,et al.  Clostridium difficile Infections in Veterans Health Administration Long-Term Care Facilities , 2014, Infection Control & Hospital Epidemiology.

[3]  R. Polk,et al.  Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. , 2014, Infectious disease clinics of North America.

[4]  J. Stevens,et al.  Cost-effectiveness of a modified two-step algorithm using a combined glutamate dehydrogenase/toxin enzyme immunoassay and real-time PCR for the diagnosis of Clostridium difficile infection. , 2014, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[5]  D. Gerding,et al.  Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  D. Siraj,et al.  Impact of Regular Collaboration Between Infectious Diseases and Critical Care Practitioners on Antimicrobial Utilization and Patient Outcome* , 2013, Critical care medicine.

[7]  Mulugeta Gebregziabher,et al.  The impact of penicillin skin testing on clinical practice and antimicrobial stewardship. , 2013, Journal of hospital medicine.

[8]  Y. Carmeli,et al.  Epidemiological Interpretation of Studies Examining the Effect of Antibiotic Usage on Resistance , 2013, Clinical Microbiology Reviews.

[9]  C. Robertson,et al.  Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum β-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus. , 2013, International journal of antimicrobial agents.

[10]  E. P. Dellinger,et al.  Clinical practice guidelines for antimicrobial prophylaxis in surgery. , 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[11]  S. Trottier,et al.  Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Motasem A. Aldiab,et al.  An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. , 2012, The Journal of antimicrobial chemotherapy.

[13]  R. Porcher,et al.  Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study. , 2012, The Journal of antimicrobial chemotherapy.

[14]  Neil O. Fishman,et al.  Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS) , 2012, Infection Control & Hospital Epidemiology.

[15]  X. Fang,et al.  Decreased Resistance of Pseudomonas aeruginosa with Restriction of Ciprofloxacin in a Large Teaching Hospital's Intensive Care and Intermediate Care Units , 2012, Infection Control & Hospital Epidemiology.

[16]  S. Rizzo,et al.  Reduction in Fluoroquinolone Use following Introduction of Ertapenem into a Hospital Formulary Is Associated with Improvement in Susceptibility of Pseudomonas aeruginosa to Group 2 Carbapenems: a 10-Year Study , 2011, Antimicrobial Agents and Chemotherapy.

[17]  R. Leclercq,et al.  Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis. , 2011, The Journal of hospital infection.

[18]  R. Kullar,et al.  Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Richard Colgan,et al.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  X. Fang,et al.  Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus aureus and Clostridium difficile infections following implementation of an electronic medical record at a tertiary-care teaching hospital. , 2011, The Journal of antimicrobial chemotherapy.

[21]  M. Rotondo,et al.  Active surveillance screening of MRSA and eradication of the carrier state decreases surgical-site infections caused by MRSA. , 2009, Journal of the American College of Surgeons.

[22]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  D. Holbert,et al.  Effect of reduction in ciprofloxacin use on prevalence of meticillin-resistant Staphylococcus aureus rates within individual units of a tertiary care hospital. , 2006, The Journal of hospital infection.

[24]  S. Michie,et al.  Interventions to improve antibiotic prescribing practices for hospital inpatients. , 2017, The Cochrane database of systematic reviews.

[25]  R. Polk,et al.  Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. , 2004, The Journal of antimicrobial chemotherapy.

[26]  Y. Carmeli,et al.  Fluoroquinolones and the Risk for Methicillin-resistant Staphylococcus aureus in Hospitalized Patients , 2003, Emerging infectious diseases.

[27]  B. Dale,et al.  Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. , 2003, The Journal of hospital infection.

[28]  D. Maki,et al.  The Commonality of Risk Factors for Nosocomial Colonization and Infection with Antimicrobial-Resistant Staphylococcus aureus, Enterococcus, Gram-Negative Bacilli, Clostridium difficile, and Candida , 2002, Annals of Internal Medicine.

[29]  C. Kelly,et al.  Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.